8-K//Current report
TNF Pharmaceuticals, Inc. 8-K
Accession 0001641172-25-027052
$QCLSCIK 0001321834operating
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:00 PM ET
Size
1.8 MB
Accession
0001641172-25-027052
Documents
- 8-Kform8-k.htmPrimary
8-K
- EX-3.1ex3-1.htm
EX-3.1
- EX-3.2ex3-2.htm
EX-3.2
- EX-3.3ex3-3.htm
EX-3.3
- EX-3.4ex3-4.htm
EX-3.4
- EX-99.1ex99-1.htm
EX-99.1
- EX-101.SCHtnfa-20250904.xsd
XBRL SCHEMA FILE
- EX-101.LABtnfa-20250904_lab.xml
XBRL LABEL FILE
- EX-101.PREtnfa-20250904_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001641172-25-027052-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLform8-k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Q/C TECHNOLOGIES, INC.
CIK 0001321834
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001321834
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 5:00 PM ET
- Size
- 1.8 MB